Attention Deficit Hyperactivity Disorder in Children: Comparative Efficacy of Traditional Chinese Medicine and Methylphenidate

被引：14

作者：

Lan, Y. ^{[1
]}

Zhang, L-L ^{[1
]}

Luo, R. ^{[2
]}

机构：

[1] Sichuan Univ, W China Hosp 2, Dept Pharmaceut, Chengdu 610041, Peoples R China

[2] Sichuan Univ, W China Hosp 2, Children Nerves & Digest Dept, Chengdu 610041, Peoples R China

来源：

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2009年 / 37卷 / 03期

关键词：

TRADITIONAL CHINESE MEDICINE; METHYLPHENIDATE; ATTENTION DEFICIT HYPERACTIVITY DISORDERS; ADHD; CHILDREN;

D O I：

10.1177/147323000903700340

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Traditional Chinese medicine (TCM) is frequently used to treat attention deficit hyperactivity disorders (ADHD) in children in China. However, until now there has been no strong evidence to prove that TCM has better efficacy than western medicine. In this systematic study of 34 studies published in the Chinese literature, the effectiveness of TCM in treating ADHD in children was examined and compared with methylphenidate (MPH), which is widely. used to treat ADHD. It was found that TCM may have equal or better effectiveness than MPH. However, the lack of high-quality clinical trials to support this conclusion means that it is not currently possible to recommend any particular kind of TCM preparation for treating ADHD in children.

引用

页码：939 / 948

页数：10

共 50 条

[31] Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
Raveen Hanwella
Madhri Senanayake
Varuni de Silva
BMC Psychiatry, 11
[32] Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
Hanwella, Raveen
Senanayake, Madhri
de Silva, Varuni
BMC PSYCHIATRY, 2011, 11
[33] EFFICACY OF METHYLPHENIDATE AMONG MENTALLY-RETARDED CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
HANDEN, BL
BREAUX, AM
GOSLING, A
PLOOF, DL
FELDMAN, H
PEDIATRICS, 1990, 86 (06) : 922 - 930
[34] EVIDENCE OF EFFICACY AND SAFETY OF METHYLPHENIDATE IN THE TREATMENT OF CHILDREN OR ADOLESCENTS WITH ATTENTION DEFICIT DISORDER AND HYPERACTIVITY (ADHD)
Leite, B. F.
Vidal, J. S.
Silva, A. S.
Brito, G., V
Souza, K. M.
Freitas, M. G.
Vieira, N. C.
Wichmann, R.
Silveira, D. S.
VALUE IN HEALTH, 2015, 18 (07) : A837 - A837
[35] Methylphenidate for Attention-Deficit/Hyperactivity Disorder
Romanos, Marcel
Reif, Andreas
Banaschewski, Tobias
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 994 - 995
[36] Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder
Kummer, Arthur
Teixeira, Antonio
AUSTRALASIAN PSYCHIATRY, 2008, 16 (06) : 458 - 459
[37] USE OF METHYLPHENIDATE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER
不详
CANADIAN MEDICAL ASSOCIATION JOURNAL, 1990, 142 (08) : 817 - 818
[38] Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
Tan, M
Appleton, R
ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (01) : 57 - 59
[39] Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder
Pae, Chi-Un
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (05): : 1149 - 1150
[40] Methylphenidate and attention-deficit hyperactivity disorder
Mellis, Craig
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2016, 52 (03) : 354 - 355

← 1 2 3 4 5 →